Visit our TwitterVisit our LinkedIn

Appropriate selection of patients for 1st line monotherapy in advanced or unresectable HCC and treatment management in relation with AEs
Pre-Meeting Survey

If you wish to view the details for the meeting, then please click the button. 
2. On a scale of 1 to 5, how confident are you (with 5 as extremely confident) in understanding the efficacy profile of the VEGFR-TKI monotherapies? *
3. On a scale of 1 to 5, how confident are you (with 5 as extremely confident) in understanding the safety profile of the VEGFR-TKI monotherapies? *
4. On a scale of 1 to 5, how confident (with 5 as extremely confident) are you in understanding which patients could benefit from VEGFR-TKI monotherapy? *
5. On a scale of 1 to 5, how familiar (with 5 as extremely familiar) are you in the management of AEs and adapting the dosing strategy? *
7. Do you have a patient case study you are able to share to be discussed in the breakout sessions? If you select YES then we can discuss over email *
COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.
Bodenackerstrasse 17
4103 Bottmingen
Switzerland
Disclaimer: The material and content contained in the website engage.cor2ed.com is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved 
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept
View Cookie Policy